Timothy Price

33PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jan 13, 2026
Impact of Metformin and Diabetes on Tumor Response to Total Neoadjuvant Therapy in Advanced Rectal Cancer: A Multicenter Retrospective Cohort Study.

Sergei Bedrikovetski, Mahima Raju, Tracy Fitzsimmons

|Dec 30, 2025
Identification of Novel Susceptibility Genes for Early-Onset Colorectal Cancer Through Germline Rare Variant Burden Testing.

Ruocen Song, Reger R Mikaeel, Zhongping He

|Oct 29, 2025
Bacterial Infections and Their Cell Wall Ligands Differentially Modulate Doxorubicin Sensitivity in Triple-Negative Breast Cancer Cells.

Sima Kianpour Rad, Runhao Li, Kenny K L Yeo

|May 02, 2025
A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours.

Timothy Price, Iwona Lugowska, Sant P Chawla

|Mar 27, 2025
A phase 1 study to assess the safety, tolerability and effectiveness of PV-10 (Rose Bengal Sodium) in neuroendocrine tumours metastatic to the liver.

Timothy Price, Laura Depauw, Gabrielle Cehic

|Mar 26, 2025
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial.

Desmond Yip, John Zalcberg, Jean-Yves Blay

Pageof 6

Frequent Collaborators

5 joint publications

Eric Smith

4 joint publications

Jennifer E Hardingham

3 joint publications

Joanne P Young

3 joint publications

Tharani Krishnan